ArticleACS omega2025
Fabrication of Aligned Polyhydroxybutyrate Fibrous Scaffolds via a Touchspinning Apparatus.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From Waste to Treasure: Therapeutic Horizons of Polyhydroxyalkanoates in Modern Medicine.Pharmaceutics · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Poly-(3-hydroxybutyrate) (PHB) fibers ranging from nano- to microscale were successfully fabricated using a touchspinning apparatus. The optimization of key spinning parametersincluding solution concentration (5-11% w/v), rotational speed (1300-2100 rpm), and feed rate (5-20 μL/min)enabled the production of aligned fibrous scaffolds. Morphological analysis via field emission scanning electron microscopy (FE-SEM) revealed fiber diameters in the range of 0.831-1.273 μm, which were influenced by spinning conditions. Thermal stability was confirmed using thermogravimetric analysis (TGA), with an onset degradation temperature of ∼290 °C. Differential scanning calorimetry (DSC) showed a melting peak of ∼172 °C and a crystallinity increase from 37.9% in the pellet to 42.5% in fibers of PHB. The scaffolds were functionalized with collagen to enhance bioactivity, and fibroblast (NIH3T3) viability was assessed through alamarBlue and Live/Dead assays. Metabolic activity increased significantly over 5 days (
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.